Clinical Trials Browser

Pancreatic Neoplasms

Pancreatic Cancer Metastatic

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Esophageal Squamous Cell Carcinoma

Colonic Neoplasms

Breast Cancer Metastatic

Neoplasms, Second Primary

Colorectal Neoplasms

Carcinoma, Ovarian Epithelial, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Small Cell, Neuroendocrine Tumors

Colorectal Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colorectal Neoplasms

Pancreatic Neoplasms

Colorectal Cancer Metastatic

Colorectal Neoplasms

Advanced Pancreatic Cancer

Colorectal Neoplasms

Cholangiocarcinoma

Stomach Neoplasms

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

Bile Duct Neoplasms, Gallbladder Neoplasms

Pancreatic Neoplasms

Extensive Stage Small Cell Lung Cancer

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Esophageal Neoplasms

Colorectal Neoplasms

Overall Survival

Pancreatic Neoplasms

Colonic Neoplasms

Stomach Neoplasms

Sarcoma, Sarcoma, Ewing

Esophageal Neoplasms, Stomach Neoplasms

Neuroblastoma, Ganglioneuroblastoma

Pancreatic Adenocarcinoma

Sarcoma, Ewing

Pancreatic Metastatic Cancer

Neuroblastoma

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Brain Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

Small Cell Lung Carcinoma

Clinical Trials

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

PASS-01

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Hepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver

Pancreas

Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas

Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer

Phenomenal

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

NAUTICALCRC

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

NIVACOR

Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab

AVETRIC

Ph 2 Trial of Vitamin C & G-FLIP (Low Doses Gemcitabine, 5FU, Leucovorin, Irinotecan, Oxaliplatin) for Pancreatic Cancer

SULTAN

Side Effects to FOLFOXIRI + Tocotrienol/Placebo as First Line Treatment of Metastatic Colorectal Cancer

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab

TRITICC

Docetaxel and Irinotecan in Gastric Cancer

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

Trifluridine/Tipiracil and Irinotecan for the Treatment of Advanced Refractory Biliary Tract Cancer

Irinotecan and Docetaxel With or Without Cetuximab in Treating Patients With Metastatic Pancreatic Cancer

Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Radiation Therapy and Chemotherapy Before and After Surgery in Treating Patients With Esophageal Cancer

Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

VOLFI

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

AFEMA

Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer

mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer

A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

Chemotherapy Combined With Apatinib and PD-1 Antibody

A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma

Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer

Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

EW-2

PAMELA70

N2011-01

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

IMPROVE

External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas

A Comparison of mXELIRI Regimen and FOLFIRI Combined Bevacizumab Regimen as First-line Chemotherapy Regimen for Metastatic Colorectal Cancer

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

Efficacy of Chemotherapy, Associated to Either Cetuximab or Bevacizumab, in KRAS Wild-type Metastatic Colorectal Cancer Patients With Progressive Disease After Receiving First-line Treatment With Bevacizumab

Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer